Bioactivity | NBI 35965 methanesulfonate is a selective, orally active and brain-penetrant corticotropin-releasing factor receptor 1 (CRF1) antagonist with a Ki value of 4 nM and a pKi value of 8.5. NBI 35965 methanesulfonate does not inhibit CRF2. NBI 35965 methanesulfonate reduces CRF or stress-induced adrenocorticotropic hormone (ACTH) production in vivo with pIC50 values of 7.1 and 6.9, respectively. NBI 35965 methanesulfonate shows anxiolytic effects[1][2]. |
Invitro | NBI 35965 methanesulfonate 对 CRF1 表现出高亲和力,但对 CRF2 没有结合亲和力。在 CRF1 转染细胞中,NBI 35965 methanesulfonate 还可抑制 Sauvineine 诱导的 cAMP 刺激[2]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> NBI 35965 methanesulfonate 相关抗体: |
In Vivo | NBI 35965 methanesulfonate(20 mg/kg;口服灌胃;一次)可减少小鼠应激诱导的 ACTH 产生[1]。在大鼠中,NBI 35965 methanesulfonate(化合物 12a;10mg/kg)的分布容积为 17.8 L/kg,血浆清除率为 17 mL/min/kg,半衰期为 12 小时。估计口服生物利用度为 34%,1 小时平均最大血浆浓度为 560 ng/mL。NBI 35965 methanesulfonate 也能穿透血脑屏障,导致平均最大脑浓度为 700 ng/g[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: |
CAS | 603151-83-3 |
Formula | C22H26Cl2N4O3S |
Molar Mass | 497.44 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Gross RS, et al. Design and synthesis of tricyclic corticotropin-releasing factor-1 antagonists. J Med Chem. 2005 Sep 8;48(18):5780-93. [2]. Mulugeta Million, et al. A novel water-soluble selective CRF1 receptor antagonist, NBI 35965, blunts stress-induced visceral hyperalgesia and colonic motor function in rats. Brain Res. 2003 Sep 19;985(1):32-42. |